Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 9, 2012, Pages 837-845

  Matsuura, Yunosuke ^a,b   Hatakeyama, Kinta ^b   Imamura, Takuroh ^a   Tsuruda, Toshihiro ^a   Shibata, Yoshisato ^c   Kodama, Tatsuhiko ^d   Kitamura, Kazuo ^a   Asada, Yujiro ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Miyazaki Medical Association Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

C reactive protein (CRP); Coronary artery disease; Intraplaque hemorrhage; Macrophages; Pentraxin 3 (PTX3)

Indexed keywords

C REACTIVE PROTEIN; CD163 ANTIGEN; PENTRAXIN 3;

ADULT; ARTICLE; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; PHENOTYPE; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA, STABLE; ANGINA, UNSTABLE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHERECTOMY, CORONARY; AUTOPSY; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CELL SURFACE; SERUM AMYLOID P-COMPONENT;

EID: 84867902782     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.12526     Document Type: Article

References (36)

1. Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874
2. Libby P, Ridker PM, Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol, 2009; 54: 2129-2138
3. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S: An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb, 2010; 17: 1-11
4. Homma Y: Predictors of atherosclerosis. J Atheroscler Thromb, 2004; 11: 265-270
5. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S: C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol, 2004; 24: 1509-1515
6. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M: C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med, 2009; 151: 483-495
7. Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E: Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE ITTIMI 22. Arterioscler Thromb Vasc Biol, 2009; 29: 424-430
8. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22. Investigators: C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005; 352: 20-28
9. Ferreirós ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, Bazzino OO: Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation, 1999; 100: 1958-1963
10. Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology, 1990; 12: 1179-1186
11. Presta M, Camozzi M, Salvatori G, Rusnati M: Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med, 2007; 11: 723-738
12. Mantovani A, Garlanda C, Doni A, Bottazzi B: Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol, 2008; 28: 1-13
13. Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T: Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol, 2007; 27: 161-167
14. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A; Lipid Assessment Trial Italian Network (LATIN) Investigators: Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation, 2004; 110: 2349-2354
15. Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM: Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 2009; 29: 594-599
16. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, Kitajima S, Morimoto M, Watanabe T, Asada Y, Chen YE, Fan J: C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol, 2005; 167: 1139-1148
17. Rolph MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK: Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 2002; 22: e10-e14
18. Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, Emura I, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Naito M: Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol, 2008; 215: 48-55
19. Ishikawa T, Hatakeyama K, Imamura T, Date H, Shibata Y, Hikichi Y, Asada Y, Eto T: Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol, 2003; 91: 287-292
20. Sato Y, Hatakeyama K, Yamashita A, Marutsuka K, Sumiyoshi A, Asada Y: Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart, 2005; 91: 526-530
21. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb, 1994; 14: 840-856
22. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol, 1995; 15: 1512-1531
23. Nishihira K, Imamura T, Yamashita A, Hatakeyama K, Shibata Y, Nagatomo Y, Date H, Kita T, Eto T, Asada Y: Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J, 2006; 27: 1685-1689
24. Solem J, Levin M, Karlsson T, Grip L, Albertsson P, Wiklund O: Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment. J Intern Med, 2006; 259: 267-275
25. Garlanda C, Bottazzi B, Bastone A, Mantovani A: Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol, 2005; 23: 337-366
26. Bottazzi B, Bastone A, Doni A, Garlanda C, Valentino S, Deban L, Maina V, Cotena A, Moalli F, Vago L, Salustri A, Romani L, Mantovani A: The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol, 2006; 79: 909-912
27. van Rossum AP, Pas HH, Fazzini F, Huitema MG, Limburg PC, Jonkman MF, Kallenberg CG: Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum, 2006; 54: 986-991
28. Maina V, Cotena A, Doni A, Nebuloni M, Pasqualini F, Milner CM, Day AJ, Mantovani A, Garlanda C: Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol, 2009; 86: 123-132
29. Graversen JH, Madsen M, Moestrup SK: CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol, 2002; 34: 309-314
30. Yunoki K, Naruko T, Komatsu R, Ehara S, Shirai N, Sugioka K, Nakagawa M, Kitabayashi C, Ikura Y, Itoh A, Kusano K, Ohe T, Haze K, Becker AE, Ueda M: Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes. Eur Heart J, 2009; 30: 1844-1852
31. Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO: Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol, 2009; 174: 1097-1108
32. Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A: Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol, 2006; 79: 797-802
33. Polentarutti N, Picardi G, Basile A, Cenzuales S, Rivolta A, Matteucci C, Peri G, Mantovani A, Introna M: Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes. Eur J Immunol, 1998; 28: 496-501
34. Van Vré EA, Bult H, Hoymans VY, Van Tendeloo VF, Vrints CJ, Bosmans JM: Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler Thromb Vasc Biol, 2008; 28: 511-518
35. Devaraj S, Jialal I. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol, 2011; 31: 1397-1402
36. Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL: Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation, 2009; 120: 699-708